Combining Anti-Angiogenesis and Immunotherapy Enhances Antitumor Effect by Promoting Immune Response in Lung Cancer

被引：10

作者：

Zhao, Sha ^{[1
]}

Jiang, Tao ^{[2
]}

Li, Xuefei ^{[3
]}

Zhou, Caicun ^{[4
]}

机构：

[1] Tongji Univ, Dept Med Oncol, Shanghai Pulm Hosp, Thorac Canc Inst,Sch Med, Shanghai, Peoples R China

[2] Tongji Univ, Dept Med Oncol, Shanghai Pulm Hosp, Sch Med, Shanghai, Peoples R China

[3] Tongji Univ, Lung Canc & Immun Lab, Shanghai Pulm Hosp, Med Sch,Pulm Canc Inst, Shanghai, Peoples R China

[4] Tongji Univ, Oncol, Shanghai Pulm Hosp, Sch Med,Canc Inst, Shanghai, Peoples R China

来源：

关键词：

programmed death ligand-1; lung cancer; Immunotherapy; angiogenesis;

D O I：

10.1016/j.jtho.2016.11.293

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA11.07

引用

页码：S288 / S288

页数：1